Did you mean?
Search Results - Showing 0 - 12 Of 42
_aacr-journals-webinar-on-car-t-cell-manufacturing.jpg "Hosted by Blood Cancer Discovery, a panel of experts, representing major stakeholders, identify and discuss actionable points to spearhead innovation and harmonization of the CAR T cell manufacturing process.")
⏲ 36 min 14 sec ✓ 29-Sep-2021
_automated-car-t-cell-manufacturing.jpg "Miltenyi Biotec")
⏲ 5 minutes 2 seconds 👁 17.2K
_car-t-cell-therapy-explained-manufacturing-process-amp-how-it-works.jpg "Henrik's Lab")
⏲ 3 minutes 14 seconds 👁 29.1K
_advances-in-car-t-manufacture-bridging-the-commercialization-gaps.jpg "Against the backdrop of continued promising clinical data and approvals for an increasing range of indications, CAR-T cell therapies look set to become an integral part of modern healthcare. As the field continues to develop, it's an opportune time to reflect on the progress thus far and, more importantly, look at the key lessons we have learnt from the early challenges faced.nnThis webinar will provide insight into:nnThe critical gaps in our knowledge and understanding of the CAR-T manufacturin")
⏲ 35 min 23 sec ✓ 29-Jun-2018
_manufacturing-car-t-cell-therapies-the-novartis-approach.jpg "Novartis")
⏲ 2 minutes 14 seconds 👁 46.7K
_a-cgmp-compatible-non-viral-car-t-cell-manufacturing-process.jpg "Labroots")
⏲ 57 minutes 19 seconds 👁 1.1K
_case-studies-in-cell-amp-gene-therapy-process-optimization.jpg "Hear from leading expert Dr David DiGiusto, Stanford University School of Medicine, USA, as he shares his extensive experience in developing and optimizing manufacturing processes for cell and gene therapy products including:nnThe unique challenges of utilizing different cell types such as bi-specific CAR-T cells, regulatory T cells and hematopoietic stem cells.nSpecific approaches taken to overcome these challenges including optimizing cell processing steps such as isolation, washing, expansion")
⏲ 34 min 78 sec ✓ 19-Jan-2018
_meet-paula-quality-control-for-car-t-manufacturing.jpg "Novartis")
⏲ 2 minutes 53 seconds 👁 6.1K
_employing-car-t-therapies-in-earlier-lines-of-large-b-cell-lymphoma-treatment.jpg "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
⏲ 1 minute 24 seconds 👁 16
_cell-and-gene-therapies-and-the-dawn-of-the-next-chapter-of-biopharmaceutical-production.jpg "What are some of the unique challenges and opportunities in commercializing live modalities like CAR-T?nWeighing the pros and cons of centralized versus decentralized production models for these new treatmentsnDiscussing how our industry’s quality culture informs these new products from R&D right through to the patientnOffering lessons learned from the first generation of cell and gene therapies. How will their example inform what we are doing now?nSetting timelines for the future: What ar")
⏲ 20 min 46 sec ✓ 19-Nov-2019
_the-cell-therapy-process-bms-cell-therapy-manufacturing-tour.jpg "Bristol Myers Squibb")
⏲ 3 minutes 51 seconds 👁 10.6K
_a-shortcut-through-process-development-for-car-t-cell-manufacturing-webinar.jpg "Miltenyi Biotec")
⏲ 32 minutes 1 second 👁 430
Related Searches
Search Videos
Recent Searches
_aacr-journals-webinar-on-car-t-cell-manufacturing.webp "Hosted by Blood Cancer Discovery, a panel of experts, representing major stakeholders, identify and discuss actionable points to spearhead innovation and harmonization of the CAR T cell manufacturing process.")
_automated-car-t-cell-manufacturing.webp "Miltenyi Biotec")
_car-t-cell-therapy-explained-manufacturing-process-amp-how-it-works.webp "Henrik's Lab")
_advances-in-car-t-manufacture-bridging-the-commercialization-gaps.webp "Against the backdrop of continued promising clinical data and approvals for an increasing range of indications, CAR-T cell therapies look set to become an integral part of modern healthcare. As the field continues to develop, it's an opportune time to reflect on the progress thus far and, more importantly, look at the key lessons we have learnt from the early challenges faced.nnThis webinar will provide insight into:nnThe critical gaps in our knowledge and understanding of the CAR-T manufacturin")
_manufacturing-car-t-cell-therapies-the-novartis-approach.webp "Novartis")
_a-cgmp-compatible-non-viral-car-t-cell-manufacturing-process.webp "Labroots")
_case-studies-in-cell-amp-gene-therapy-process-optimization.webp "Hear from leading expert Dr David DiGiusto, Stanford University School of Medicine, USA, as he shares his extensive experience in developing and optimizing manufacturing processes for cell and gene therapy products including:nnThe unique challenges of utilizing different cell types such as bi-specific CAR-T cells, regulatory T cells and hematopoietic stem cells.nSpecific approaches taken to overcome these challenges including optimizing cell processing steps such as isolation, washing, expansion")
_meet-paula-quality-control-for-car-t-manufacturing.webp "Novartis")
_employing-car-t-therapies-in-earlier-lines-of-large-b-cell-lymphoma-treatment.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_cell-and-gene-therapies-and-the-dawn-of-the-next-chapter-of-biopharmaceutical-production.webp "What are some of the unique challenges and opportunities in commercializing live modalities like CAR-T?nWeighing the pros and cons of centralized versus decentralized production models for these new treatmentsnDiscussing how our industry’s quality culture informs these new products from R&D right through to the patientnOffering lessons learned from the first generation of cell and gene therapies. How will their example inform what we are doing now?nSetting timelines for the future: What ar")
_the-cell-therapy-process-bms-cell-therapy-manufacturing-tour.webp "Bristol Myers Squibb")
_a-shortcut-through-process-development-for-car-t-cell-manufacturing-webinar.webp "Miltenyi Biotec")
![[+]](/images/menu.gif){kind=small}